These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10353937)
1. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Carlsson AK; Axelsson IE; Borulf SK; Bredberg AC; Lindberg BA; Sjöberg KG; Ivarsson SA Pediatrics; 1999 Jun; 103(6 Pt 1):1248-52. PubMed ID: 10353937 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome. Carlsson A; Axelsson I; Borulf S; Bredberg A; Forslund M; Lindberg B; Sjöberg K; Ivarsson SA Pediatrics; 1998 Feb; 101(2):272-5. PubMed ID: 9445503 [TBL] [Abstract][Full Text] [Related]
3. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies. Baudon JJ; Johanet C; Absalon YB; Morgant G; Cabrol S; Mougenot JF Arch Pediatr Adolesc Med; 2004 Jun; 158(6):584-8. PubMed ID: 15184223 [TBL] [Abstract][Full Text] [Related]
4. Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease. Del Rosario MA; Fitzgerald JF; Chong SK; Croffie JM; Gupta SK J Pediatr Gastroenterol Nutr; 1998 Aug; 27(2):191-5. PubMed ID: 9702652 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Koehne Vde B; Bahia M; Lanna CC; Pinto MR; Bambirra EA; Cunha AS Arq Gastroenterol; 2010; 47(3):250-6. PubMed ID: 21140085 [TBL] [Abstract][Full Text] [Related]
6. Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Catassi C; Fanciulli G; D'Appello AR; El Asmar R; Rondina C; Fabiani E; Bearzi I; Coppa GV Scand J Gastroenterol; 2000 Jul; 35(7):732-6. PubMed ID: 10972177 [TBL] [Abstract][Full Text] [Related]
8. [The correlation of IgA-class antigliadin and antiendomysial antibodies (AGA-IgA--EmA-IgA) with the intestinal histology in celiac disease (CD)]. de Rosa S; Litwin N; de Dávila MT; Ruiz JA; Guastavino E; de Pini A; Queralt AM Acta Gastroenterol Latinoam; 1992; 22(3):161-7. PubMed ID: 1341115 [TBL] [Abstract][Full Text] [Related]
12. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age. Lagerqvist C; Dahlbom I; Hansson T; Jidell E; Juto P; Olcén P; Stenlund H; Hernell O; Ivarsson A J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):428-35. PubMed ID: 18852634 [TBL] [Abstract][Full Text] [Related]
13. Screening by anti-endomysium antibody for celiac disease in diabetic children and adolescents in Austria. Schober E; Bittmann B; Granditsch G; Huber WD; Hüppe A; Jäger A; Oberhuber G; Rami B; Reichel G J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):391-6. PubMed ID: 10776949 [TBL] [Abstract][Full Text] [Related]
14. Down syndrome and coeliac disease: usefulness of antigliadin and antiendomysium antibodies. Bonamico M; Rasore-Quartino A; Mariani P; Scartezzini P; Cerruti P; Tozzi MC; Cingolani M; Gemme G Acta Paediatr; 1996 Dec; 85(12):1503-5. PubMed ID: 9001668 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of IgA class antigliadin and antiendomysial antibodies (IgA-AGA-IgA-EMA) with intestinal histology in celiac disease]. De Rosa S; Litwin N; Dávila MT; Ruiz JA; Guastavino E; Pini A; Queralt AM Acta Gastroenterol Latinoam; 1993; 23(1):19-25. PubMed ID: 8237260 [TBL] [Abstract][Full Text] [Related]
16. IgA endomysium antibodies--an early predictor for celiac disease in children without villous atrophy. Grodzinsky E; Fälth-Magnusson K; Högberg L; Jansson G; Laurin P; Stenhammar L Acta Paediatr; 2008 Jul; 97(7):972-6. PubMed ID: 18489624 [TBL] [Abstract][Full Text] [Related]
17. Association between anti-endomysial antibody and total intestinal villous atrophy in children with coeliac disease. Ozgenc F; Aksu G; Aydogdu S; Akman S; Genel F; Kutukculer N; Alkanat MB; Vural Yagci R J Postgrad Med; 2003; 49(1):21-4; discussion 24. PubMed ID: 12865566 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus. Ashabani A; Abushofa U; Abusrewill S; Abdelazez M; Tucková L; Tlaskalová-Hogenová H Diabetes Metab Res Rev; 2003; 19(1):69-75. PubMed ID: 12592646 [TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. Shamaly H; Hartman C; Pollack S; Hujerat M; Katz R; Gideoni O; Shamir R J Pediatr Gastroenterol Nutr; 2007 May; 44(5):583-6. PubMed ID: 17460490 [TBL] [Abstract][Full Text] [Related]
20. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers. Matteucci E; Cinapri V; Quilici S; Lucchetti A; Mugnaini P; Giampietro O Diabetes Nutr Metab; 2001 Feb; 14(1):37-42. PubMed ID: 11345164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]